Jump to navigation
Consider precautions beyond handwashing and vaccination say authors.
Its use changed diagnosis in a quarter of patients
But it is not yet subsidised in Australia
There is no requirement for them to be validated.
It's important to keep a watch on these women throughout life, researchers say.
A score for HbA1c variability is suggested.
The safety profile is similar to IV administration.
'Another reason for patients to take off a few pounds'
But long-term effects must be examined, a critic says.
Preliminary results put denosumab ahead
Australian Doctor Group (ADG) is Australia’s premier business to business publisher, delivering the country’s most recognised industry magazines and websites.
Ensure you never miss a big story by signing up for our daily e-newsletter.